Oleg K Glebov

Title: Oleg K Glebov: Innovator in Carcinogen Assays

Introduction

Oleg K Glebov is a notable inventor based in Germantown, MD (US). He has made significant contributions to the field of carcinogen detection through his innovative methods and assays. His work focuses on the early determination of whether a test agent is a carcinogen, which is crucial for public health and safety.

Latest Patents

Oleg K Glebov holds 1 patent for his invention titled "Carcinogen assay." This patent presents novel methods and assays that correlate the pattern of differential gene expression from mammalian cells treated with a test agent to reference patterns from known carcinogens. The invention also includes methods for using DNA and RNA isolated from treated cells, as well as kits that comprise these materials. Additionally, it outlines methods for determining carcinogenicity by measuring protein synthesis or post-translational modifications in treated mammalian cells.

Career Highlights

Throughout his career, Oleg K Glebov has demonstrated a commitment to advancing scientific knowledge in the area of carcinogen detection. His innovative approaches have the potential to significantly impact the way carcinogens are identified and studied.

Collaborations

Oleg has collaborated with notable colleagues such as Jeffrey M Ostrove and Flavia Borellini. These partnerships have likely contributed to the development and refinement of his innovative assays.

Conclusion

Oleg K Glebov's work in carcinogen assays exemplifies the importance of innovation in the field of health and safety. His contributions are vital for the early detection of potential carcinogens, ultimately benefiting public health.